Medication info
Ranigen Tablet

Ranigen Tablet

Prescription medicationTabletOralExpired
Ingredient · strength
Ranitidine Hydrochloride›84mg / 1 tabletTripotassium Bismuth Dicitrate›100mg / 1 tabletSucralfate Hydrate›300mg / 1 tablet
Manufacturer / importer
Teragen Etex Co., Ltd.
Appearance
Round white film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Expired

MFDS item code 201402228 · Approved 2014.05.14

This product's status changed to Expired on 2026.01.28. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of acid-related disorders (including ulcers and gastritis); prevention of Mendelson syndrome during anesthesia
Who takes it
Adults
Adult dose
Usually, take 2 tablets orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Take 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by taking 4 tablets twice daily, in the morning and at bedtime. The dose is the same for ulcers caused by nonsteroidal anti-inflammatory drugs or for combination therapy to prevent gastric or duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drugs generally heal within 4 weeks, and ulcers generally heal within 8 weeks, although healing may take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Gastroesophageal reflux disease For 8 weeks, take 2 tablets twice daily or 4 tablets once daily at bedtime. For patients with severe gastroesophageal reflux disease, the dose may be increased to 4 tablets 4 times daily. 3) Zollinger-Ellison syndrome Initiate treatment with 2 tablets 3 times daily and increase the dose as necessary. In severe cases, up to 6 g of ranitidine daily may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcer, acute stress ulcer, or acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and take 2 tablets twice daily. 5) Premedication for anesthesia (prevention of Mendelson's syndrome) Administer 2 tablets 2 hours before induction of anesthesia. It is also preferable to administer 2 tablets on the evening before surgery.

Ingredients

Manufacturer
Teragen Etex Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (including ulcers and gastritis); prevention of Mendelson syndrome during anesthesia

  • Gastric ulcer
  • duodenal ulcer
  • gastritis
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • post-surgical ulcer
  • NSAID-induced gastric ulcer
  • NSAID-induced duodenal ulcer
View approved original text

This medication is used for gastrointestinal diseases such as gastric ulcers, duodenal ulcers, gastritis, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also administered to prevent Mendelson's syndrome before anesthesia, and it aids in treating ulcers post-surgery. It is effective for gastric and duodenal ulcers that may arise from the use of non-steroidal anti-inflammatory drugs (NSAIDs). It is used to alleviate these conditions.

How to take

Adult dose

Usually, take 2 tablets orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Take 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by taking 4 tablets twice daily, in the morning and at bedtime. The dose is the same for ulcers caused by nonsteroidal anti-inflammatory drugs or for combination therapy to prevent gastric or duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drugs generally heal within 4 weeks, and ulcers generally heal within 8 weeks, although healing may take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Gastroesophageal reflux disease For 8 weeks, take 2 tablets twice daily or 4 tablets once daily at bedtime. For patients with severe gastroesophageal reflux disease, the dose may be increased to 4 tablets 4 times daily. 3) Zollinger-Ellison syndrome Initiate treatment with 2 tablets 3 times daily and increase the dose as necessary. In severe cases, up to 6 g of ranitidine daily may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcer, acute stress ulcer, or acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and take 2 tablets twice daily. 5) Premedication for anesthesia (prevention of Mendelson's syndrome) Administer 2 tablets 2 hours before induction of anesthesia. It is also preferable to administer 2 tablets on the evening before surgery.

Precautions

This drug should not be used in patients undergoing dialysis or those with kidney function issues. In addition, individuals who have shown allergic reactions to this drug or its components should avoid taking it. Patients with a rare condition called acute porphyria should also be cautious, as symptoms may worsen with this medication. It is not recommended for patients who have undergone upper gastrointestinal surgery, pregnant women or those who could become pregnant, preterm infants and newborns, as well as patients who need to restrict potassium intake. Patients with liver function issues, those with a history of drug allergies, the elderly, and those with a history of renal impairment should use this medication cautiously. In cases where non-steroidal anti-inflammatory drugs are being used, particularly elderly patients or those with a history of peptic ulcers, regular monitoring of their condition is necessary. This medication can mask symptoms of gastric cancer, so patients with gastric ulcers or those who recently developed or had changes in dyspeptic symptoms, especially those over middle age, should confirm whether it is not a malignant condition before treatment. Patients with Helicobacter pylori infection and gastric or duodenal ulcers require eradication treatment. Caution is also needed for critically ill patients, those with hypophosphatemia, and patients with swallowing difficulties when using this drug. This medication rarely can cause serious allergic reactions or shock, so if any abnormal symptoms appear during administration, it should be stopped immediately, and medical personnel should be consulted. Allergic reactions such as skin rash, hives, angioedema, fever, bronchospasm may also occur, and these should prompt discontinuation of the medication. Blood-related side effects such as leukopenia, thrombocytopenia, and liver dysfunction may be reported, and if symptoms occur, immediate reporting to medical personnel is necessary. Gastrointestinal symptoms may include nausea, vomiting, constipation, diarrhea, abdominal pain, and changes in stool color may occur, but these do not require special treatment. CNS-related symptoms may include dizziness, drowsiness, confusion, seizures, insomnia, and headaches, especially in patients with poor kidney function. Rarely, side effects such as gynecomastia, erectile dysfunction, myalgia, skin rash, and hair loss may occur. Long-term use should be avoided, and if there is no therapeutic effect, other medications should be considered. The elderly or immunocompromised patients may be at increased risk for pneumonia, so caution is advised. If experiencing dizziness or drowsiness, avoid driving or operating dangerous machinery. This medication may interact with other drugs, so inform your healthcare provider if you are currently taking other medications. It is safe to avoid using this medication for women who are pregnant or breastfeeding. Safety in pediatric patients has not been established, so it is advisable not to use it. In cases of overdose, emergency treatment such as vomiting or gastric lavage may be needed, and blood dialysis may help in certain cases.

Side effects

  • anaphylactic shock
  • skin rash
  • urticaria
  • angioedema
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • leukopenia
Show 58 more
  • thrombocytopenia
  • elevated serum enzyme levels
  • agranulocytosis
  • pancytopenia
  • bone marrow hypoplasia
  • aplastic anemia
  • aplastic anemia
  • acquired immune hemolytic anemia
  • eosinophilia
  • elevated AST
  • elevated ALT
  • elevated r-GTP
  • elevated ALP
  • jaundice hepatitis
  • non-jaundice hepatitis
  • tachycardia
  • bradycardia
  • atrioventricular block
  • premature ventricular contraction
  • arrhythmia
  • vasculitis
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • dizziness
  • drowsiness
  • confusion
  • convulsion
  • excitement
  • insomnia
  • headache
  • heaviness in the head
  • malaise
  • anxiety
  • delirium
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorder
  • consciousness disorder
  • hepatic muscle cramps
  • gynecomastia
  • hyperprolactinemia
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • alopecia
  • glossitis
  • pruritus
  • mucocutaneous syndrome
  • toxic epidermal necrolysis
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly sealed container to prevent air from entering, and it is best kept at room temperature between 1 and 30 degrees Celsius. By following these storage instructions, the effectiveness of the medication can be preserved for a longer duration.

Appearance and packaging

Appearance

Round white film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.